---
schema_version: "secwatch.filing_event.v1"
accession: "0000950142-23-000586"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T13:17:14.928008+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# NRx Pharma shareholders approve stock issuance to Streeterville Capital

## Summary
- Stockholders approved issuance of common shares to Streeterville Capital, LLC under Nasdaq Listing Rule 5635(d).
- Vote results: 38,338,555 for, 311,870 against, 373,843 abstentions.
- Special meeting reconvened on March 3, 2023, with quorum present throughout.
- Approval allows company to proceed with share issuance, potentially for financing or debt conversion.

## SEC filing metadata
- accession: 0000950142-23-000586
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/0000950142-23-000586-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/eh230336011_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950142-23-000586
- JSON: https://secwatch.observer/filing/0000950142-23-000586.json
- Plain text: https://secwatch.observer/filing/0000950142-23-000586.txt

## Key facts
- Shareholder Votes
  NRX Pharmaceuticals, Inc. shareholders approved Approval of issuance of shares of common stock to Streeterville Capital, LLC in accordance with Nasdaq Listing Rule 5635(d) at the 2023-03-03 meeting.
  - Outcome: passed
  - Meeting: 2023-03-03
  source text: The Company’s stockholders approved approve the issuance of shares of common stock to Streeterville Capital, LLC in accordance with Nasdaq Listing Rule 5635(d). The results of the voting were as follows: Votes For Votes Against Abstentions 38,338,555 311,870 373,843
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/0000950142-23-000586-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.